NV
Novo Integrated Sciences, Inc.
NVOS · OTC
$0.00 +0.00% (+$0.00)
1M +550.00%
Market Cap $76.9K
P/E Ratio -
Div. Yield -
ROE 91.57%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
P/B 0.01x
P/E N/A
Growth
61 /100
Stable Rev. growth 12.63%
Book val. growth 30.24%
EPS growth N/A
Profitability
17 /100
Weak Gross margin 43.20%
FCF margin 38.17%
Net margin 121.61%
Quality
5 /100
Poor ROIC 40.13%
Asset turnover 0.41x
ROE 91.57%
Debt
46 /100
Moderate Debt/Equity 0.32x
Int. coverage -1.23x
Current ratio 0.37x
Stability
26 /100
Unstable Beta 5.83x
Profitable years 0
Rev. volatility 11.40%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NVOS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert Mattacchione
Employees
115
Headquarters
Bellevue